Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Aldeyra Therapeutics
ALDX
$92.9M
| $591K | ﹤0.01% |
132,908
+4,523
| +4% | +$18K |
|
3052
Dole
DOLE
$1.35B
| $591K | ﹤0.01% |
+47,590
| New | +$659K |
|
3053
Hooker Furnishings Corp
HOFT
$150M
| $590K | ﹤0.01% |
31,130
+303
| +1% | +$6.45K |
|
3054
Viking Therapeutics
VKTX
$3.7B
| $590K | ﹤0.01% |
196,410
+19,084
| +11% | +$68.5K |
|
|
GHL
3055
DELISTED
Greenhill & Co., Inc.
GHL
| $589K | ﹤0.01% |
38,083
+1,375
| +4% | +$24.1K |
|
3056
Citizens
CIA
$239M
| $585K | ﹤0.01% |
137,820
+4,123
| +3% | +$18.6K |
|
3057
Torrid Holdings
CURV
$254M
| $585K | ﹤0.01% |
96,410
+14,026
| +17% | +$119K |
|
3058
The ONE Group
STKS
$56.2M
| $580K | ﹤0.01% |
55,139
+2,437
| +5% | +$28.6K |
|
|
BGRY
3059
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $580K | ﹤0.01% |
201,346
+5,006
| +3% | +$17.8K |
|
3060
Matrix Service
MTRX
$326M
| $575K | ﹤0.01% |
69,831
-436,182
| -86% | -$3.29M |
|
3061
Distribution Solutions Group
DSGR
$1.6B
| $574K | ﹤0.01% |
29,784
+1,196
| +4% | +$26K |
|
3062
Spero Therapeutics
SPRO
$67.7M
| $571K | ﹤0.01% |
65,547
| – | – |
|
3063
Superior Group of Companies
SGC
$185M
| $569K | ﹤0.01% |
31,856
+1,477
| +5% | +$29.3K |
|
3064
Vor Biopharma
VOR
$1.15B
| $566K | ﹤0.01% |
4,679
+62
| +1% | +$10.6K |
|
3065
Village Super Market
VLGEA
$651M
| $565K | ﹤0.01% |
23,040
+967
| +4% | +$22.3K |
|
3066
Outlook Therapeutics
OTLK
$183M
| $564K | ﹤0.01% |
15,835
+4,832
| +44% | +$151K |
|
|
SPPI
3067
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $559K | ﹤0.01% |
432,628
+22,726
| +6% | +$20.9K |
|
3068
Tilly's
TLYS
$116M
| $557K | ﹤0.01% |
59,504
-19,969
| -25% | -$246K |
|
3069
Immunic
IMUX
$190M
| $553K | ﹤0.01% |
4,889
| – | – |
|
|
INST
3070
DELISTED
Instructure Holdings, Inc.
INST
| $551K | ﹤0.01% |
27,455
+1,342
| +5% | +$29.1K |
|
3071
Kopin
KOPN
$652M
| $550K | ﹤0.01% |
217,363
+21,912
| +11% | +$63.1K |
|
|
NBP
3072
NovaBridge Biosciences American Depositary Shares
NBP
$185M
| $548K | ﹤0.01% |
33,726
+1,370
| +4% | +$35.1K |
|
3073
Apyx Medical
APYX
$173M
| $544K | ﹤0.01% |
83,172
+2,397
| +3% | +$23.6K |
|
3074
Global Water Resources
GWRS
$206M
| $544K | ﹤0.01% |
32,684
| – | – |
|
3075
Fidelity D&D Bancorp
FDBC
$306M
| $542K | ﹤0.01% |
11,652
+1,453
| +14% | +$72.5K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.